Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mizagliflozin in chronic constipation
NCT02281630Phase 2Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Oct 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mizagliflozin in chronic constipation, sponsored by Kissei Pharmaceutical Co., Ltd.. Started Oct 2014; status: completed.
02
Drugs
mizagliflozin
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT02281630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02281630.